scispace - formally typeset
M

Madeleine M.A. Tilanus-Linthorst

Researcher at Erasmus University Rotterdam

Publications -  51
Citations -  5038

Madeleine M.A. Tilanus-Linthorst is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 30, co-authored 50 publications receiving 4672 citations.

Papers
More filters
Journal ArticleDOI

Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

Xiaohong R. Yang, +173 more
TL;DR: It is shown that reproductive factors and BMI are most clearly associated with hormone receptor-positive tumors and suggest that triple-negative or CBP tumors may have distinct etiology.
Journal ArticleDOI

First experiences in screening women at high risk for breast cancer with MR imaging.

TL;DR: Investigating whether magnetic resonance imaging in addition to the normal surveillance could detect cancers otherwise missed found it promising in screening young women at high risk for breast cancer, as it can advance the detection of cancers still occult at mammography and physical examination; but the cost may be considerable.
Journal ArticleDOI

Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173 797 patients

TL;DR: In this article, the influence of stage at breast cancer diagnosis, tumour biology, and treatment on survival in contemporary times of better (neo-)adjuvant systemic therapy was assessed.
Journal ArticleDOI

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers

Juliet D. French, +214 more
TL;DR: Analysis of 4,405 variants in 89,050 European subjects from 41 case-control studies identified three independent association signals for estrogen-receptor-positive tumors at 11q13, and Chromatin conformation studies demonstrate that these enhancer and silencer elements interact with each other and with their likely target gene, CCND1.